Utidelone Combined With Bevacizumab in the Treatment of ≥ 2 Lines of HER-2 Negative Advanced Breast Cancer
Henan Cancer Hospital
Henan Cancer Hospital
Vastra Gotaland Region
Başakşehir Çam & Sakura City Hospital
Umraniye Education and Research Hospital
National Cancer Center, Korea
Vastra Gotaland Region
Azienda Sanitaria Locale di Asti
Tuen Mun Hospital
Moscow Regional Oncological Dispensary
University Hospital, Angers
University Hospital, Angers
Nanchong Central Hospital
Nanchong Central Hospital
Henan Cancer Hospital
Nanchong Central Hospital
Nanchong Central Hospital
Nanchong Central Hospital
Nanchong Central Hospital
Fujian Cancer Hospital
Health Institutes of Turkey
Institute of Health Information and Statistics of the Czech Republic
Unidade Local de Saúde São João
Taipei Veterans General Hospital, Taiwan
Queensland Centre for Gynaecological Cancer
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Clinical Hub for Interventional Research (CHOIR)
Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology
N.N. Alexandrov National Cancer Centre
N.N. Alexandrov National Cancer Centre
Fujian Cancer Hospital
University Hospital, Angers
Turku University Hospital
University Hospital, Angers
Fujian Cancer Hospital
Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Ankara Etlik City Hospital
Queensland Centre for Gynaecological Cancer
Tata Memorial Hospital
Tata Memorial Hospital
Taipei Veterans General Hospital, Taiwan
The Affiliated People's Hospital of Ningbo University
National Cancer Center, Korea
Tata Memorial Hospital
Jinnah Postgraduate Medical Centre
EDDC (Experimental Drug Development Centre), A*STAR Research Entities
Queensland Centre for Gynaecological Cancer
Kayseri City Hospital
Anhui Provincial Hospital
Vastra Gotaland Region
Sheba Medical Center